Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist-Reference-Cited by-同舟云学术

Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist

Published:2020-07-07 Issue:12 Volume:60 Page:1606-1616
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Polepally Akshanth R.¹^ORCID,Ng Juki W.²,Salem Ahmed Hamed³^ORCID,Dufek Matthew B.³,Parikh Apurvasena¹,Carter David C.³,Kamradt Kent³,Mostafa Nael M.³,Shebley Mohamad³^ORCID

Affiliation:

1. Clinical Pharmacology and Pharmacometrics AbbVie Inc. Redwood City California USA

2. Pharmaceutical Development, General Medicine AbbVie Inc. North Chicago Illinois USA

3. Clinical Pharmacology and Pharmacometrics AbbVie Inc. North Chicago Illinois USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1689

Reference38 articles.

1. Assessing research gaps and unmet needs in endometriosis

2. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids

3. Orilissa™ (elagolix) [package insert]. North Chicago IL: AbbVie Inc.;2018.

Clinical Utility Of Elagolix As An Oral Treatment For Women With Uterine Fibroids: A Short Report On The Emerging Efficacy Data

5. Oriahnn™ (co‐package of elagolix estradiol and norethindrone acetate capsules and elagolix capsules) [package insert]. North Chicago IL: AbbVie Inc.; 2020.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling;Drug Metabolism and Disposition;2024-05-13

2. Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women;Clinical Pharmacology in Drug Development;2024-04-09

3. The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023;Drug Metabolism and Disposition;2023-07-05

4. Combined Oral Contraceptives As Victims of Drug Interactions;Drug Metabolism and Disposition;2023-03-24

5. Virtual Bioequivalence Assessment of Elagolix Formulations Using Physiologically Based Pharmacokinetic Modeling;The AAPS Journal;2023-03-22